BsaB เปิดตัว Diffuser กลิ่นใหม่ Tobacco & Cedarwood ที่มาพร้อมความ
THB 0.00
bsab BsAb therapies contain antigen-binding sites that target proteins on both tumor cells and immune effector When a BsAb interacts with target antigens,
BsAb therapies contain antigen-binding sites that target proteins on both tumor cells and immune effector When a BsAb interacts with target antigens, bsab bsAb using a common LC in combination with a KiH Fc is emicizumab developed by Chugai, which targets factor IXa and factor X
ปริมาณ:
bsab BsAb therapies contain antigen-binding sites that target proteins on both tumor cells and immune effector When a BsAb interacts with target antigens,
bsab BsAb therapies contain antigen-binding sites that target proteins on both tumor cells and immune effector When a BsAb interacts with target antigens,
bsAb using a common LC in combination with a KiH Fc is emicizumab developed by Chugai, which targets factor IXa and factor X